This is true non-response, and it affects roughly 10 to 15% of people who try semaglutide
There may be difficulties in having to refrigerate the injectable versions
Some providers said they guide their patients about how to stay on the medications and still enjoy their favorite treats, for example, by trying smaller portion sizes
Combined Protocol Example The following represents a typical 16-week protocol for someone starting both compounds: Tirzepatide: Weekly injection, following standard escalation from 2.5mg to 10mg over 16 weeks HGH: 2 IU upon waking (fasted) daily for weeks 1-4, increasing to 3 IU daily weeks 5-16 Cycle Length: 16-24 weeks, followed by 4-8 week break from HGH (Tirzepatide can continue) Monitoring: Bloodwork at baseline, week 8, and week 16 minimum This conservative approach allows proper adaptation to both compounds while providing meaningful body composition results
Understanding Semaglutide Semaglutide, an FDA-approved GLP-1 receptor agonist, serves adults with obesity or overweight conditions and those having at least one weight-related health issue
Any use of such names is solely for identification purposes and is in compliance with the provisions of the Trademark Act, 1999, including principles of fair use
